BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17106247)

  • 1. Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse.
    Ignatenko NA; Holubec H; Besselsen DG; Blohm-Mangone KA; Padilla-Torres JL; Nagle RB; de Alboránç IM; Guillen-R JM; Gerner EW
    Cancer Biol Ther; 2006 Dec; 5(12):1658-64. PubMed ID: 17106247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations.
    Yang K; Fan K; Kurihara N; Shinozaki H; Rigas B; Augenlicht L; Kopelovich L; Edelmann W; Kucherlapati R; Lipkin M
    Carcinogenesis; 2003 Mar; 24(3):605-11. PubMed ID: 12663524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc deletion rescues Apc deficiency in the small intestine.
    Sansom OJ; Meniel VS; Muncan V; Phesse TJ; Wilkins JA; Reed KR; Vass JK; Athineos D; Clevers H; Clarke AR
    Nature; 2007 Apr; 446(7136):676-9. PubMed ID: 17377531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.
    Lin S; Lee SJ; Shim H; Chun J; Yun CC
    Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1128-38. PubMed ID: 20724530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
    Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
    Int J Exp Pathol; 2009 Oct; 90(5):558-74. PubMed ID: 19765110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stat6 Promotes Intestinal Tumorigenesis in a Mouse Model of Adenomatous Polyposis by Expansion of MDSCs and Inhibition of Cytotoxic CD8 Response.
    Jayakumar A; Bothwell ALM
    Neoplasia; 2017 Aug; 19(8):595-605. PubMed ID: 28654863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Krüppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations.
    Nandan MO; Ghaleb AM; McConnell BB; Patel NV; Robine S; Yang VW
    Mol Cancer; 2010 Mar; 9():63. PubMed ID: 20298593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
    Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
    Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the ApcMin/+ mouse small intestine.
    Patek CE; Arends MJ; Rose L; Luo F; Walker M; Devenney PS; Berry RL; Lawrence NJ; Ridgway RA; Sansom OJ; Hooper ML
    BMC Gastroenterol; 2008 Jun; 8():24. PubMed ID: 18554389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse.
    Erdman SH; Ignatenko NA; Powell MB; Blohm-Mangone KA; Holubec H; Guillén-Rodriguez JM; Gerner EW
    Carcinogenesis; 1999 Sep; 20(9):1709-13. PubMed ID: 10469614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.
    Nandi B; Pai C; Huang Q; Prabhala RH; Munshi NC; Gold JS
    PLoS One; 2014; 9(5):e97566. PubMed ID: 24866282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
    Liu S; Tackmann NR; Yang J; Zhang Y
    Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism between K-rasVal12 and mutant Apc accelerates murine large intestinal tumourigenesis.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Arends MJ
    Oncol Rep; 2011 Jul; 26(1):125-33. PubMed ID: 21573497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice.
    Xiao H; Yin W; Khan MA; Gulen MF; Zhou H; Sham HP; Jacobson K; Vallance BA; Li X
    Gastroenterology; 2010 Aug; 139(2):574-85. PubMed ID: 20416302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of Itf2 promotes intestinal tumorigenesis in Apc(Min/+) mice.
    Grill JI; Herbst A; Brandl L; Kong L; Schneider MR; Kirchner T; Wolf E; Kolligs FT
    Biochem Biophys Res Commun; 2015 May; 461(2):249-53. PubMed ID: 25869068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Cox2 gene deletion in intestinal epithelial cells decreases tumorigenesis in female, but not male, ApcMin/+ mice.
    Cherukuri DP; Ishikawa TO; Chun P; Catapang A; Elashoff D; Grogan TR; Bugni J; Herschman HR
    Mol Oncol; 2014 Mar; 8(2):169-77. PubMed ID: 24268915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice.
    Smits R; Ruiz P; Diaz-Cano S; Luz A; Jagmohan-Changur S; Breukel C; Birchmeier C; Birchmeier W; Fodde R
    Gastroenterology; 2000 Oct; 119(4):1045-53. PubMed ID: 11040191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.
    Yamada Y; Hata K; Hirose Y; Hara A; Sugie S; Kuno T; Yoshimi N; Tanaka T; Mori H
    Cancer Res; 2002 Nov; 62(22):6367-70. PubMed ID: 12438216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered intestinal epithelium-associated lymphocyte repertoires and function in ApcMin/+ mice.
    Marsh L; Coletta PL; Hull MA; Selby PJ; Carding SR
    Int J Oncol; 2012 Jan; 40(1):243-50. PubMed ID: 21879254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.